REGENERON PHARMACEUTICALS, INC. SEC Filings
REGNLatest REGENERON PHARMACEUTICALS, INC. (REGN) SEC filings and EDGAR documents — 8-K current reports, 10-K/10-Q, Form 4 insider trades, with AI summaries.
Quarterly Report · ended 2026-06-30 · Rev $4.3B, NI $1.3B
Earnings Release; Financial Statements
RYAN ARTHUR F sold 200 shares of Common Stock at $650.15 on 2026-07-02
8-K current report
8-K current report
RYAN ARTHUR F sold 5 shares of Common Stock at $701.76 on 2026-05-01; RYAN ARTHUR F sold 15 shares of Common Stock at $702.46 on 2026-05-01; RYAN ARTHUR F sold 24 shares of Common Stock at $703.46 on 2026-05-01; RYAN ARTHUR F sold 14 shares of Common Stock at $705.56 on 2026-05-01; RYAN ARTHUR F sold 7 shares of Common Stock at $706.74 on 2026-05-01
REGENERON PHARMACEUTICALS, INC. filed 10-Q on 2026-04-29
8-K current report
8-K current report
RYAN ARTHUR F sold 1 shares of Common Stock at $771.32 on 2026-04-01; RYAN ARTHUR F sold 3 shares of Common Stock at $772.76 on 2026-04-01; RYAN ARTHUR F sold 8 shares of Common Stock at $773.59 on 2026-04-01; RYAN ARTHUR F sold 14 shares of Common Stock at $775.58 on 2026-04-01; RYAN ARTHUR F sold 13 shares of Common Stock at $776.62 on 2026-04-01
RYAN ARTHUR F sold 7 shares of Common Stock at $777.46 on 2026-03-02; RYAN ARTHUR F sold 2 shares of Common Stock at $778.30 on 2026-03-02; RYAN ARTHUR F sold 5 shares of Common Stock at $779.69 on 2026-03-02; RYAN ARTHUR F sold 3 shares of Common Stock at $780.69 on 2026-03-02; RYAN ARTHUR F sold 10 shares of Common Stock at $783.62 on 2026-03-02
Zoghbi Huda Y bought 1,638 shares of Common Stock at $376.69 on 2026-02-19; Zoghbi Huda Y sold 49 shares of Common Stock at $774.68 on 2026-02-19; Zoghbi Huda Y sold 50 shares of Common Stock at $775.50 on 2026-02-19; Zoghbi Huda Y sold 53 shares of Common Stock at $778.47 on 2026-02-19; Zoghbi Huda Y sold 208 shares of Common Stock at $779.55 on 2026-02-19
Pitofsky Jason bought 1,000 shares of Common Stock at $492.00 on 2026-02-09; Pitofsky Jason sold 20 shares of Common Stock at $775.95 on 2026-02-09; Pitofsky Jason sold 521 shares of Common Stock at $776.43 on 2026-02-09; Pitofsky Jason sold 391 shares of Common Stock at $777.51 on 2026-02-09; Pitofsky Jason sold 563 shares of Common Stock at $778.35 on 2026-02-09
RYAN ARTHUR F sold 1 shares of Common Stock at $775.63 on 2026-02-09; RYAN ARTHUR F sold 10 shares of Common Stock at $776.59 on 2026-02-09; RYAN ARTHUR F sold 57 shares of Common Stock at $777.56 on 2026-02-09; RYAN ARTHUR F sold 12 shares of Common Stock at $778.53 on 2026-02-09; RYAN ARTHUR F sold 5 shares of Common Stock at $779.41 on 2026-02-09
REGENERON PHARMACEUTICALS, INC. filed 10-K on 2026-02-04
8-K current report
8-K current report
Bassler Bonnie L bought 1,500 shares of Common Stock at $374.12 on 2026-01-07; Bassler Bonnie L sold 1,500 shares of Common Stock at $800.00 on 2026-01-07; Bassler Bonnie L sold 1,500 shares of Non-Qualified Stock Option (right to buy) at $N/A on 2026-01-07
Guarini Kathryn bought 155 shares of Common Stock at $N/A on 2026-01-02; Guarini Kathryn bought 1,962 shares of Non-Qualified Stock Option (right to buy) at $N/A on 2026-01-02
Bassler Bonnie L bought 155 shares of Common Stock at $N/A on 2026-01-02; Bassler Bonnie L bought 1,962 shares of Non-Qualified Stock Option (right to buy) at $N/A on 2026-01-02